Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Impact of tuberculosis cotreatment on viral suppression rates among HIV-positive children initiating HAART.

Zanoni BC, Phungula T, Zanoni HM, France H, Feeney ME.

AIDS. 2011 Jan 2;25(1):49-55. doi: 10.1097/QAD.0b013e32833f9e04.

PMID:
20935555
2.

Immune mediated 'HAART' attack during treatment for tuberculosis. Highly active antiretroviral therapy.

Kunimoto DY, Chui L, Nobert E, Houston S.

Int J Tuberc Lung Dis. 1999 Oct;3(10):944-7. Review.

PMID:
10524594
4.

Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy.

DeSimone JA, Pomerantz RJ, Babinchak TJ.

Ann Intern Med. 2000 Sep 19;133(6):447-54. Review.

PMID:
10975963
5.

[Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].

Pozio E.

Parassitologia. 2004 Jun;46(1-2):89-93. Review. Italian.

PMID:
15305694
6.

Tuberculosis and HIV co-infection: a practical therapeutic approach.

Breen RA, Swaden L, Ballinger J, Lipman MC.

Drugs. 2006;66(18):2299-308. Review.

PMID:
17181373
7.

Tuberculosis in patients infected with the human immunodeficiency virus.

Gerard M.

Monaldi Arch Chest Dis. 1998 Dec;53(6):688-92. Review. No abstract available.

PMID:
10063346
8.

Tuberculosis in children.

Perez-Velez CM, Marais BJ.

N Engl J Med. 2012 Jul 26;367(4):348-61. doi: 10.1056/NEJMra1008049. Review. No abstract available.

PMID:
22830465
9.

Fever of unknown origin in the setting of HIV infection: guidelines for a rational approach.

Mayo J, Collazos J, Martinez E.

AIDS Patient Care STDS. 1998 May;12(5):373-8. Review.

PMID:
11361973

Supplemental Content

Support Center